Epstein-barr virus induces erosive arthritis in humanized mice

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kuwana, Yoshikazu ^a   Takei, Masami ^a   Yajima, Misako ^b   Imadome, Ken Ichi ^c   Inomata, Hirotake ^a   Shiozaki, Masaaki ^a   Ikumi, Natsumi ^a   Nozaki, Takamasa ^a   Shiraiwa, Hidetaka ^a   Kitamura, Noboru ^a   Takeuchi, Jin ^a   Sawada, Shigemasa ^a   Yamamoto, Naoki ^b   Shimizu, Norio ^d   Ito, Mamoru ^e   Fujiwara, Shigeyoshi ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE MARROW EDEMA; CD3+ T LYMPHOCYTE; CD34 SELECTION; CD4 CD8 RATIO; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EROSIVE ARTHRITIS; GRANULATION TISSUE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; IMMUNE SYSTEM; INFLAMMATORY CELL; MOUSE; NONHUMAN; PANNUS; RHEUMATOID ARTHRITIS; SYNOVIUM; UMBILICAL CORD BLOOD; ANIMAL; BONE MARROW; DISEASE MODEL; FEMALE; HUMAN; JOINT; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ANIMALIA; HUMAN HERPESVIRUS 4; MUS;

ANIMALS; ARTHRITIS; BONE MARROW; DISEASE MODELS, ANIMAL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; JOINTS; MICE;

EID: 80054828318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026630     Document Type: Article

References (21)

1. Alspaugh MA, Jensen FC, Rabin H, Tan EM, (1978) Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147: 1018-1027.
2. Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH, (1983) Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci U S A 80: 7104-7108.
3. Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH, (1985) Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 134: 211-216.
4. Rumpold H, Rhodes GH, Bloch PL, Carson DA, Vaughan JH, (1987) The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). J Immunol 138: 593-599.
5. Fox R, Sportsman R, Rhodes G, Luka J, Pearson G, et al. (1986) Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J Clin Invest 77: 1539-1547.
6. Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA, (1988) The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol 27: 367-371.
7. Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, et al. (1997) Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 9: 739-743.
8. Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, et al. (2003) Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 48: 1223-1228.
9. Lunemann JD, Frey O, Eidner T, Baier M, Roberts S, et al. (2008) Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol 181: 991-1000.
10. Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, et al. (1996) T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 184: 1791-1800.
11. Tosato G, Steinberg AD, Blaese RM, (1981) Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 305: 1238-1243.
12. Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, et al. (1984) Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73: 1789-1795.
13. Filipovich AH, Zhang K, Snow AL, Marsh RA, (2010) X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 116: 3398-3408.
14. Takei M, Ishiwata T, Mitamura K, Fujiwara S, Sasaki K, et al. (2001) Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol 13: 559-565.
15. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, et al. (2008) A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198: 673-682.
16. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, et al. (2009) T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 200: 1611-1615.
17. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, et al. (2007) Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109: 212-218.
18. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, et al. (2007) Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 81: 13259-13264.
19. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, et al. (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37: 132-136.
20. Ochi T, Hakomori S, Adachi M, Owaki H, Okamura M, et al. (1988) The presence of a myeloid cell population showing strong reactivity with monoclonal antibody directed to difucosyl type 2 chain in epiphyseal bone marrow adjacent to joints affected with rheumatoid arthritis (RA) and its absence in the corresponding normal and non-RA bone marrow. J Rheumatol 15: 1609-1615.
21. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA, (1989) Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A 86: 5104-5108.